Jake Jorgovan

NOVEMBER 27, 2023

Biopharmaceutical Consulting: Supporting every aspect of the biopharma value chain, including R&D, operations, manufacturing, commercialization, and mergers and acquisitions (M&A). is a prominent global provider specializing in advanced analytics, technology solutions, and clinical research services for the life sciences industry.

Life science 130

Life science Biopharmaceuticals Biotech Mergers and acquisition activities 130

Frost & Sullivan

OCTOBER 14, 2022

Parexel combines in-house expertise, patient and caregiver insights, and cutting-edge technologies to plan, operationalize, and deliver DCTs for biopharmaceutical customers worldwide while ensuring the highest levels of patient safety.

Biopharmaceuticals 98

Biopharmaceuticals Life science Collaboration 98

Jake Jorgovan

NOVEMBER 15, 2023

With consultants boasting an average tenure of over 12 years in Life Sciences, they are well-positioned to meet your search requirements. Their unique value point is executive search within the life sciences and healthcare continuum. However, they operate particularly within the Montreal-Toronto-Boston triangle.

Biopharma 130

Biopharma Biotech Biotechnology Life science 130

Frost & Sullivan

JULY 19, 2021

Leveraging a leading suite of end-to-end biopharmaceutical development services covering patient-focused clinical trial design and decentralized clinical trial (DCT) strategies, the company has helped develop 198 of the 200 top-selling biopharmaceuticals in the market. About Parexel International Corporation.

Biopharmaceuticals 52

Biopharmaceuticals Life science Contract research organization 52

LaVoie Health Science Blog

DECEMBER 21, 2023

Biotech Showcase is a premier investor conference committed to creating a platform for private and micro-mid-cap biotechnology companies, offering unique opportunities to showcase innovations and engage one-to-one with investors and biopharmaceutical executives. Forge connections by networking with 350+ life science firms and 500+ investors.

Biopharmaceuticals 59

Biopharmaceuticals Biotechnology Biotech Life science 59

Frost & Sullivan

DECEMBER 16, 2020

Furthermore, LabCorp Drug Development draws on its deep expertise in antiviral drugs and vaccines, as well as partners with biopharmaceutical companies to develop treatment and vaccines for COVID-19 through improved detection methods.” Contact us: Start the discussion. Contact: Lindsey Whitaker. P: +1 (210) 477-8457. About LabCorp.

Biopharmaceuticals 98

Biopharmaceuticals Life science Contract research organization Government 98

Frost & Sullivan

APRIL 25, 2023

Emmes is a full-service, global Clinical Research Organization (CRO) committed to promoting public health and biopharmaceutical innovation. The company collaborates with biopharmaceutical, governmental, non-profit, and academic organizations to enhance its value proposition and meet client demands.

Biopharmaceuticals 52

Biopharmaceuticals Biopharma Biotechnology Contract research organization 52

LaVoie Health Science Blog

OCTOBER 5, 2020

Join a health science focused integrated communications agency and be part of the agency’s second phase of growth. Strong detail oriented public relations/communications professional needed for growing life science/biopharmaceutical practice.

Biopharmaceuticals 40

Biopharmaceuticals Biotechnology Life science Finance 40

Frost & Sullivan

DECEMBER 19, 2023

Parexel has more than 40 years of experience and 21,000+ dedicated professionals globally who successfully collaborate with biopharmaceutical leaders to design and conduct patient-focused clinical trials worldwide. Parexel leverages its in-depth RWE knowledge to identify evidence gaps and formulate evidence-generation strategies.

Biopharmaceuticals 52

Biopharmaceuticals Insurance Collaboration Life science 52

Frost & Sullivan

MARCH 30, 2021

At the same time, it is important to ensure healthcare remains precise, preventive, and outcome-based in the promotion of social and financial inclusion,” said Chandni Mathur, Healthcare & Life Sciences Senior Industry Analyst at Frost & Sullivan. Between 2021 and 2023, innovative business models are expected to emerge.

Biotechnology 98

Biotechnology Life science Government Biopharmaceuticals 98

Frost & Sullivan

AUGUST 6, 2023

“The company understands the intricacies of conducting clinical trials for innovative biopharmaceutical products, gene and cell therapies, and other advanced therapies.

Biotechnology 52

Biotechnology Biotech Contract research organization Biopharmaceuticals 52

Frost & Sullivan

MAY 3, 2023

With over 20 years of experience and more than 450 people managing 39 geographical locations throughout the Asia-Pacific region, USA, and Europe, George Clinical provides the full range of clinical trial services to biopharmaceutical, medical device, and diagnostic customers, for all trial phases, registration, and post-marketing trials.

Contract research organization 52

Contract research organization Biopharmaceuticals Biopharma Business development 52

Frost & Sullivan

MAY 16, 2022

It offers novel precision health and wellness software-as-a-service (SaaS) solutions to patients, healthcare providers (HCPs), employers, health plans, and biopharmaceuticals. The company provides a precision health-specific healthcare system and governance to improve access and awareness, thus driving adoption.

Biopharmaceuticals 52

Biopharmaceuticals Insurance Ecosystems Government 52

Frost & Sullivan

AUGUST 23, 2023

The RWE division operates in the healthcare life sciences industry, with access to 285 million lives worth of deidentified real-world data (RWD). The division of Optum focused on RWE IT solutions specializes in real-world data, health economics and outcomes research (HEOR), epidemiology, and commercial analytics.

Life science 52

Life science Biopharmaceuticals Biopharma Partnering capability and readiness 52

Frost & Sullivan

MARCH 30, 2021

At the same time, it is important to ensure healthcare remains precise, preventive, and outcome-based in the promotion of social and financial inclusion,” said Chandni Mathur, Healthcare & Life Sciences Senior Industry Analyst at Frost & Sullivan. Between 2021 and 2023, innovative business models are expected to emerge.

Biotechnology 52

Biotechnology Life science Government Biopharmaceuticals 52

Frost & Sullivan

MAY 12, 2021

May 12, 2021 – The biopharmaceutical industry is facing its biggest test in recent times. A rise in new disease outbreaks, the urgency to launch innovative therapies, and new constructs such as multi-valent antibodies are compelling biopharmaceutical companies to adopt new manufacturing approaches. SANTA CLARA, Calif. –

Biopharmaceuticals 52

Biopharmaceuticals Life science Construction Government 52

Frost & Sullivan

APRIL 3, 2024

Wuxi STA expanded its partnership with Ark Biopharmaceutical for the commercial supply of Ziresovir, a first-in-class oral antiviral for respiratory syncytial virus, which has completed the phase III clinical trial globally, for which a New Drug Application has been accepted and granted Priority Review by the China NMPA.

Biopharmaceuticals 59

Biopharmaceuticals Biopharma Biotechnology Life science 59